Zai Lab Quarterly Cash Flow Statement
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.99+0.18 (+0.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zai Lab free cash flow
In the quarter ended Jun 30, 2026, Zai Lab generated -$63.4 million of operating cash flow and spent $1.3 million on capital expenditures. That left free cash flow of -$64.7 million, a free-cash-flow margin of -60.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Zai Lab cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -50.83M | -51.02M | -50.41M | -35.96M | -40.73M | -48.44M | -81.68M | -41.67M | -80.28M | -53.47M | -95.43M | -69.15M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 4.17M | 3.94M | 3.92M | 3.90M | 3.73M | 3.46M | 3.03M | 2.87M | 2.94M | 3.01M | 2.46M | 1.92M |
| Stock-Based Compensation | 11.94M | 13.52M | 15.90M | 16.92M | 16.97M | 15.80M | 17.24M | 16.80M | 18.64M | 17.98M | 20.47M | 21.99M |
| Change in Working Capital | -23.02M | 50.19M | -10.99M | -11.89M | -13.99M | -3.35M | -45.77M | 22.20M | -3.17M | -10.68M | 37.26M | -9.52M |
| Operating Cash Flow | -63.41M | -11.91M | -26.02M | -32.04M | -31.02M | -61.70M | -55.77M | -26.82M | -42.17M | -90.11M | -14.92M | -55.27M |
| Capital Expenditures | -1.31M | -1.20M | -677.00K | -3.00M | -2.88M | -1.53M | -2.60M | -1.34M | -741.00K | -974.00K | -222.00K | -1.76M |
| Investing Cash Flow | -1.42M | -22.29M | -11.30M | -4.05M | -2.92M | 326.13M | -347.75M | -29.89M | -846.00K | 3.29M | 14.46M | -13.98M |
| Financing Cash Flow | 18.70M | 5.57M | -430.00K | 20.79M | 8.85M | 43.14M | 237.81M | 42.21M | 22.32M | 47.55M | 393.00K | -1.45M |
| Net Change in Cash | -43.79M | -28.26M | -37.58M | -15.11M | -24.99M | 307.60M | -166.42M | -13.96M | -20.73M | -39.37M | 666.00K | -70.35M |
| Free Cash Flow | -64.72M | -13.11M | -26.70M | -35.05M | -33.91M | -63.23M | -58.37M | -28.16M | -42.91M | -91.08M | -15.14M | -57.03M |
This table shows 12 quarterly periods of Zai Lab's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZLAB's reporting calendar. What is a cash flow statement?